NC

Numoda Capital Innovations

North America, Pennsylvania, United States, Philadelphia

Description

Numoda Capital Innovations is an investment firm.

Investor Profile

Numoda Capital Innovations has made 3 investments, with 0 in the past 12 months and 33% as lead.

Stage Focus

  • Series C (67%)
  • Series B (33%)

Country Focus

  • United States (100%)

Industry Focus

  • Medical
  • Pharmaceutical
  • Health Care
  • Biotechnology
  • Biopharma
  • Women's
  • Therapeutics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Numoda Capital Innovations frequently co-invest with?

RUSNANO
North America, California, United States, Menlo Park
Co-Investments: 1
Domain Associates
North America, California, United States, San Diego
Co-Investments: 2
RMI Partners
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
Alta Partners
North America, Mississippi, United States, Jackson
Co-Investments: 2
Burrill & Company
North America, California, United States, San Francisco
Co-Investments: 1
R
Europe, Moscow City, Russian Federation, Moscow
Co-Investments: 1
AMOREPACIFIC Ventures
Asia, Seoul-t'ukpyolsi, South Korea, Seoul
Co-Investments: 2

What are some of recent deals done by Numoda Capital Innovations?

Evofem Biosciences

San Diego, California, United States

Evofem is a biopharmaceutical company that offers women reproductive and contraceptive care products.

BiopharmaHealth CareMedicalWomen's
Series CDec 19, 2012
Amount Raised: $20,600,000
Neothetics

San Diego, California, United States

Neothetics is a clinical-stage specialty pharmaceutical company that develops therapeutics for the aesthetic market.

Health CarePharmaceuticalTherapeutics
Series CDec 19, 2012
Amount Raised: $20,600,000
MabVax Therapeutics

San Diego, California, United States

MabVax is a biopharmaceutical company focused on the commercialization of proprietary anti-cancer immunotherapies.

BiotechnologyMedicalPharmaceutical
Series BNov 20, 2012
Amount Raised: $5,250,000